{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:12:59Z","timestamp":1760148779775,"version":"build-2065373602"},"reference-count":84,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Heart failure is not only a global problem but also significantly limits the life prospects of these patients. The epidemiology and presentation of heart failure are intensively researched topics in cardiology. The risk factors leading to heart failure are well known; however, the real challenge is to provide effective treatments. A vicious cycle develops in heart failure of all etiologies, sooner or later compromising both cardiac and kidney functions simultaneously. This can explain the repeated hospital admissions due to decompensation and the significantly reduced quality of life. Moreover, diuretic-refractory heart failure represents a distinct challenge due to repeated hospital admissions and increased mortality. In our narrative review, we wanted to draw attention to nephrology treatment options for severe diuretic-resistant heart failure. The incremental value of peritoneal dialysis in severe heart failure and the feasibility of percutaneous peritoneal dialysis catheter insertion have been well known for many years. In contrast, the science and narrative of acute peritoneal dialysis in diuretic-resistant heart failure remains underrepresented. We believe that nephrologists are uniquely positioned to help these patients by providing acute peritoneal dialysis to reduce hospitalization dependency and increase their quality of life.<\/jats:p>","DOI":"10.3390\/life13061328","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T02:08:15Z","timestamp":1686017295000},"page":"1328","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9776-9841","authenticated-orcid":false,"given":"\u00c1kos G\u00e9za","family":"Peth\u0151","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mih\u00e1ly","family":"Tapolyai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Szent Margit K\u00f3rhaz, 1032 Budapest, Hungary"},{"name":"Medicine Service, Ralph H. Jonson VA Medical Center, Charleston, SC 29401, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Browne","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, University of Maryland Medical Center, Baltimore, MD 21201, USA"},{"name":"Medicine Service, Baltimore VA Medical Center, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3346-7040","authenticated-orcid":false,"given":"Tibor","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[{"name":"Medicine Service, Ralph H. Jonson VA Medical Center, Charleston, SC 29401, USA"},{"name":"Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petronella","family":"Orosz","sequence":"additional","affiliation":[{"name":"Bethesda Children\u2019s Hospital, 1146 Budapest, Hungary"},{"name":"Department of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-1587","authenticated-orcid":false,"given":"R\u00e9ka P.","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"ref_1","unstructured":"(2023, April 20). World Health Organization. Cardiovascular Diseases. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Back, M., von Haehling, S., Papp, Z., and Piepoli, M.F. (2023). A year in heart failure: Updates of clinical and preclinical findings. ESC Heart Fail.","DOI":"10.1002\/ehf2.14377"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.118.037778","article-title":"Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial","volume":"139","author":"Fitchett","year":"2019","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/eurheartj\/ehq337","article-title":"2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association","volume":"31","author":"Dickstein","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2021.06.040","article-title":"Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review","volume":"78","author":"Fudim","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/0960085X.2017.1398880","article-title":"Transparency in literature reviews: An assessment of reporting practices across review types and genres in top IS journals","volume":"27","author":"Templier","year":"2017","journal-title":"Eur. J. Inf. Syst."},{"key":"ref_9","unstructured":"Lau, F., and Kuziemsky, C. (2017). Handbook of eHealth Evaluation: An Evidence-Based Approach, University of Victoria."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CRD.0000000000000310","article-title":"Diuretic Resistance in Heart Failure","volume":"29","author":"Rahman","year":"2021","journal-title":"Cardiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15420\/ecr.2015.10.01.42","article-title":"Diuretic Therapy in Heart Failure\u2014Current Approaches","volume":"10","author":"Casu","year":"2015","journal-title":"Eur. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2215\/CJN.12391213","article-title":"Integrated control of Na transport along the nephron","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"F279","DOI":"10.1152\/ajprenal.00073.2007","article-title":"Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice","volume":"293","author":"Oppermann","year":"2007","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-103-1-1","article-title":"Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis","volume":"103","author":"Francis","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"ref_15","first-page":"F1256","article-title":"Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure","volume":"255","author":"Kaissling","year":"1988","journal-title":"Am. J. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ehf2.13805","article-title":"Sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: A meta-analysis","volume":"9","author":"Pandey","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00125-018-4669-0","article-title":"The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure","volume":"61","author":"Thomas","year":"2018","journal-title":"Diabetologia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.117.030012","article-title":"Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials","volume":"136","author":"Lytvyn","year":"2017","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MNH.0000000000000584","article-title":"Renal effects of SGLT2 inhibitors: An update","volume":"29","author":"Nespoux","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ehf2.12759","article-title":"Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: A case series","volume":"7","author":"Griffin","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00059-013-4041-6","article-title":"Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature","volume":"40","author":"Esposito","year":"2015","journal-title":"Herz"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1159\/000502648","article-title":"Diuretic Resistance in Cardio-Nephrology: Role of Pharmacokinetics, Hypochloremia, and Kidney Remodeling","volume":"44","author":"Masella","year":"2019","journal-title":"Kidney Blood Press. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","article-title":"Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function","volume":"39","author":"Ljungman","year":"1990","journal-title":"Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","article-title":"Abdominal contributions to cardiorenal dysfunction in congestive heart failure","volume":"62","author":"Verbrugge","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects","volume":"145","author":"Licata","year":"2003","journal-title":"Am. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/CS20070193","article-title":"Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: Is sodium an old enemy or a new friend?","volume":"114","author":"Paterna","year":"2008","journal-title":"Clin. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.RES.55.5.669","article-title":"Role of angiotensin II in the altered renal function of congestive heart failure","volume":"55","author":"Ichikawa","year":"1984","journal-title":"Circ. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000349969","article-title":"Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: Workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Haase","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kopitko, C., Medve, L., Gondos, T., Soliman, K.M.M., and Fulop, T. (2022). Mediators of Regional Kidney Perfusion during Surgical Pneumo-Peritoneum Creation and the Risk of Acute Kidney Injury-A Review of Basic Physiology. J. Clin. Med., 11.","DOI":"10.20944\/preprints202204.0166.v1"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11897-010-0009-5","article-title":"Venous congestion and endothelial cell activation in acute decompensated heart failure","volume":"7","author":"Ganda","year":"2010","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/clc.22489","article-title":"Intra-abdominal Hypertension: An Important Consideration for Diuretic Resistance in Acute Decompensated Heart Failure","volume":"39","author":"Nguyen","year":"2016","journal-title":"Clin. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.amjms.2020.01.012","article-title":"Reinterpreting Renal Hemodynamics: The Importance of Venous Congestion and Effective Organ Perfusion in Acute Kidney Injury","volume":"359","author":"Kopitko","year":"2020","journal-title":"Am. J. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: Report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fphys.2019.00310","article-title":"Peritoneal Ultrafiltration in the Long-Term Treatment of Chronic Heart Failure Refractory to Pharmacological Therapy","volume":"10","author":"Wojtaszek","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1177\/089686089601601S43","article-title":"PD treatment for severe congestive heart failure","volume":"16","author":"Stegmayr","year":"1996","journal-title":"Perit. Dial. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3747\/pdi.2012.00290","article-title":"Peritoneal ultrafiltration in refractory heart failure: A cohort study","volume":"34","author":"Bertoli","year":"2014","journal-title":"Perit. Dial. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ehf2.13118","article-title":"Congestive nephropathy: A neglected entity? Proposal for diagnostic criteria and future perspectives","volume":"8","author":"Grone","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3747\/pdi.2012.00149","article-title":"Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics","volume":"34","author":"Courivaud","year":"2014","journal-title":"Perit. Dial. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1055\/a-0768-5899","article-title":"The Cardiorenal Syndrome","volume":"144","author":"Scurt","year":"2019","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1536\/ihj.18-550","article-title":"Successful Peritoneal Dialysis for the Treatment of Inotrope-Dependent End-Stage Heart Failure","volume":"60","author":"Sugiura","year":"2019","journal-title":"Int. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.26430\/CHUNGARICA.2018.48.3.179","article-title":"A diuretikum-refrakter sz\u00edvel\u00e9gtelen betegek k\u00f6r\u00e9ben alkalmazott peritonealis dial\u00edzissel szerzett tapasztalataink","volume":"48","author":"Fedor","year":"2018","journal-title":"Cardiol. Hung."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Sun, C.Y., Sung, J.M., Wang, J.D., Li, C.Y., Kuo, Y.T., Lee, C.C., Wu, J.L., and Chang, Y.T. (2019). A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis\u2014A retrospective propensity score-matched study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223336"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3747\/pdi.2014.00340","article-title":"Peritoneal Dialysis for Heart Failure","volume":"35","author":"Puttagunta","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/ndt\/gft214","article-title":"Cost of peritoneal dialysis and haemodialysis across the world","volume":"28","author":"Karopadi","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_48","first-page":"569","article-title":"Cardiorenal syndrome: Limits of heart failure therapy","volume":"38","author":"Grossekettler","year":"2013","journal-title":"Herz"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000430084","article-title":"Peritoneal Dialysis for Chronic Congestive Heart Failure","volume":"40","author":"Francois","year":"2015","journal-title":"Blood Purif."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3747\/pdi.2018.00175","article-title":"Burden and Correlates of Hospital Readmissions among U.S. Peritoneal Dialysis Patients","volume":"39","author":"Sahlie","year":"2019","journal-title":"Perit. Dial. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0896860819895198","article-title":"The use of peritoneal dialysis in heart failure: A systematic review","volume":"40","author":"Chionh","year":"2020","journal-title":"Perit. Dial. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.jacc.2019.03.478","article-title":"ACC\/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison","volume":"73","author":"Gaggin","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_53","first-page":"145","article-title":"Risk of central venous catheter (CVC)-related bloodstream infections (CRBSI) in cancer patients (pts) with or without neutropenia at time of CVC insertion","volume":"41","author":"Schalk","year":"2018","journal-title":"Oncol. Res. Treat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.ajkd.2013.11.018","article-title":"Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients","volume":"64","author":"Hickson","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1053\/j.ajkd.2010.01.009","article-title":"Contamination of transvenous pacemaker leads due to tunneled hemodialysis catheter infection: A report of 2 cases","volume":"55","author":"Carrillo","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3747\/pdi.2011.00076","article-title":"Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentation","volume":"32","author":"Thomas","year":"2012","journal-title":"Perit. Dial. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3747\/pdi.2018.00272","article-title":"Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial","volume":"39","author":"Dukka","year":"2019","journal-title":"Perit. Dial. Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000337784","article-title":"Peritoneal dialysis solution and nutrition","volume":"178","author":"Verger","year":"2012","journal-title":"Contrib. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"vii32","DOI":"10.1093\/ndt\/gfh1105","article-title":"Peritoneal dialysis in refractory end-stage congestive heart failure: A challenge facing a no-win situation","volume":"20","author":"Gotloib","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5603\/CJ.a2014.0007","article-title":"Peritoneal ultrafiltration in end-stage congestive heart failure","volume":"21","author":"Wojtaszek","year":"2014","journal-title":"Cardiol. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjms.2016.11.003","article-title":"Peritoneal Dialysis in Class 2-3 Obesity-A Single-Center Experience","volume":"353","author":"Akula","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3747\/pdi.2018.00232","article-title":"Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update","volume":"39","author":"Crabtree","year":"2019","journal-title":"Perit. Dial. Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/1744-9987.13945","article-title":"Outcomes of early-start peritoneal dialysis (PD) and the comparison with urgent-start hemodialysis and conventional-start PD","volume":"27","author":"Yeter","year":"2023","journal-title":"Ther. Apher. Dial."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/1744-9987.13907","article-title":"Safety of a 24-h-or-less break-in period in elderly patients undergoing urgent-start peritoneal dialysis: A multicenter retrospective cohort study","volume":"27","author":"Cheng","year":"2023","journal-title":"Ther. Apher. Dial."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/08968608221083781","article-title":"Urgent-start peritoneal dialysis: Association with outcomes","volume":"43","author":"Karpinski","year":"2023","journal-title":"Perit. Dial. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/0886022X.2022.2049306","article-title":"Feasibility of a break-in period of less than 24 hours for urgent start peritoneal dialysis: A multicenter study","volume":"44","author":"Wen","year":"2022","journal-title":"Ren. Fail."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13054-020-03024-z","article-title":"Peritoneal dialysis for COVID-19-associated acute kidney injury","volume":"24","author":"Nagatomo","year":"2020","journal-title":"Crit. Care"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/0896860820931235","article-title":"Acute peritoneal dialysis in COVID-19","volume":"40","author":"Parapiboon","year":"2020","journal-title":"Perit. Dial. Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1681\/ASN.2020050599","article-title":"Acute Start Peritoneal Dialysis during the COVID-19 Pandemic: Outcomes and Experiences","volume":"31","author":"Patel","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ekir.2020.11.038","article-title":"Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19-Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center","volume":"6","author":"Bowes","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s11255-014-0738-6","article-title":"Different outcomes of peritoneal catheter percutaneous placement by nephrologists using a trocar versus the Seldinger technique: The experience of two Brazilian centers","volume":"46","author":"Ponce","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.5301\/jva.5000439","article-title":"Percutaneous versus surgical insertion of PD catheters in dialysis patients: A meta-analysis","volume":"16","author":"Boujelbane","year":"2015","journal-title":"J. Vasc. Access"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3747\/pdi.2013.00003","article-title":"Comparison of Percutaneous and Open Surgical Techniques for First-Time Peritoneal Dialysis Catheter Placement in the Unbreached Peritoneum","volume":"35","author":"Medani","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/0886022X.2019.1614058","article-title":"Bedside placement of peritoneal dialysis catheters\u2014A single-center experience from Hungary","volume":"41","author":"Petho","year":"2019","journal-title":"Ren. Fail."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1055\/s-0028-1123401","article-title":"Neues Instrument zur Ausf\u00fchrung von Brust- oder Bauchpunktionen und Pneumothoraxbehandlung","volume":"64","author":"Veress","year":"2009","journal-title":"DMW\u2014Dtsch. Med. Wochenschr."},{"key":"ref_76","unstructured":"Szab\u00f3 R\u00e9ka, S.A.P., Attila, K., \u00c1kos, P., Attila, S., Zolt\u00e1n, S., and J\u00f3zsef, B. (2016). Barna Istv\u00e1n (Szerk.) Orvosi Esettanulm\u00e1nyok-Hypertonai \u00e9s Nephrol\u00f3gia Budapest, SpringMed Kiad\u00f3."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"184","DOI":"10.26430\/CHUNGARICA.2018.48.3.184","article-title":"Peritonealis dial\u00edzis, mint \u201cbridge\u201d ter\u00e1pia a sz\u00edvtranszplant\u00e1ci\u00f3ig","volume":"48","author":"Szegedi","year":"2018","journal-title":"Cardiol. Hung."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e024194","DOI":"10.1136\/bmjopen-2018-024194","article-title":"Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: A retrospective study","volume":"9","author":"Tominaga","year":"2019","journal-title":"BMJ Open"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ehj.2004.04.023","article-title":"Haemoglobin predicts survival in patients with chronic heart failure: A substudy of the ELITE II trial","volume":"25","author":"Sharma","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/ehf2.13265","article-title":"Iron deficiency in heart failure","volume":"8","author":"Loncar","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ehf2.14177","article-title":"Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency","volume":"10","author":"Sindone","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): An investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"Ezzitouny","year":"2022","journal-title":"ESC Heart Fail."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/6\/1328\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:48:57Z","timestamp":1760125737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/6\/1328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":84,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["life13061328"],"URL":"https:\/\/doi.org\/10.3390\/life13061328","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2023,6,6]]}}}